Daily Investor Briefing: Wall Street rises on hopes for relief...

	Click to View in Browser 08/11/2014 Wall Street rises on hopes for relief on Russia worry NEW YORK (Reuters) - U.S. stocks ended higher for a second session on Monday as investors focused on hopes for easing tensions between Ukraine and Russia. Exclusive: Private equity seeks assurances from U.S. regulators over loans (Reuters) - The private equity industry's lobbying group met officials from the Office of the Comptroller of the Currency and the Federal Reserve last week to address concerns over a crackdown on junk-rated loans, people familiar with the matter said on Monday. What's left on the menu? Russian restaurateurs wrangle with food ban MOSCOW (Reuters) - Moscow's sweeping sanctions on European food have sent Russian restaurateurs, retail chains and food producers scrambling for alternative supplies and bracing for Soviet-style shortages. After offshore oil failure, Cuba shifts energy focus HAVANA (Reuters) - Cuba has shifted its focus away from offshore oil, concentrating on renewable energy and improving output from onshore wells due to a lack of interest by foreign companies for further deepwater exploration, sources close to the industry say. Postal Service loses $2 billion in second quarter WASHINGTON (Reuters) - The U.S. Postal Service continued to bleed money during its second quarter, despite an increase in package revenues and an emergency price hike that took effect in January. Exclusive: ValueAct CEO says Valeant does not need to buy Allergan NEW YORK (Reuters) - ValueAct Capital, a top shareholder in Valeant Pharmaceuticals International Inc , supports the company's independent business plan and does not believe the Canadian drugmaker has to buy Allergan Inc , the investor told Reuters on Monday. Exclusive: RBS confirms it's considering sale of Coutts' international arm ZURICH/SINGAPORE (Reuters) - Royal Bank of Scotland confirmed it was considering selling the international arm of its private bank, a deal one source said could net it as much as $1 billion, as the British government leans on it to focus more on domestic lending. Exclusive: GlaxoSmithKline faces fresh drug bribery claims in Syria LONDON (Reuters) - GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country. ArcelorMittal's Brazil head says local price outlook stable SAO PAULO (Reuters) - ArcelorMittal does not see any need to cut local steel prices in Brazil despite a weakening economy and a higher level of imports, the company's head of operations in Brazil said on Monday. U.S. watchdog calls bitcoin 'Wild West' of finance WASHINGTON (Reuters) - Virtual currencies such as bitcoin are the "Wild West" of financial products because of risks including huge swings in exchange rates, the U.S. Consumer Financial Protection Bureau said on Monday. Related Video Priceline top pick in online travel-Macquarie's Tom White Where will Pres. Erdogan take Turkey? Related News Four reasons to ignore market timing and focus on happiness Exclusive: Private equity seeks assurances from U.S. regulators over loans A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend